Concepedia

Kinjal Sanghavi

KS

Statistics

Publications

12

Citations

489

H-Index

12

Active since

2015

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Minnesota

Hennepin County Medical Center

University of Alabama

Orthopaedic Research Foundation

Kinjal Sanghavi is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacy, and cancer immunotherapy.

Publications per year

2015–2024

12

Publications

12

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles

William S. Oetting, David P. Schladt, W. Guan et al. · American Journal of Transplantation · 2015 · 116 citations · Full text

, , +17

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

Kinjal Sanghavi, Richard C. Brundage, Michael B. Miller et al. · The Pharmacogenomics Journal · 2015 · 79 citations

, , +14

Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors

Lillian L. Siu, Howard A. Burris, Dung T. Le et al. · Cancer Research · 2018 · 64 citations

, , +17

Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors

Kinjal Sanghavi, Jason Zhang, Xiaochen Zhao et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 41 citations · Full text

, , +16

Covariate modeling in pharmacometrics: General points for consideration

Kinjal Sanghavi, Jakob Ribbing, James A. Rogers et al. · CPT Pharmacometrics & Systems Pharmacology · 2024 · 40 citations · Full text

, , +13

1–5 of 12